A 30 year old female patient, on treatment for infertility, came with 6 weeks of amenorrhea, abdominal pain, and mild vaginal bleeding. Her beta hCG level was 2800 mIU/mL. On ultrasound, a 3cm mass was seen in the left adnexa. It contained a gestational sac with no fetal cardiac activity. What is the most appropriate management for this patient ? hCG- Human Chronic Gonadotropin

Explanation

## Correct Answer: D. Single dose methotrexate This is an unruptured ectopic pregnancy with a viable gestational sac (though without fetal cardiac activity) and a hCG level of 2800 mIU/mL—the classic presentation for medical management with methotrexate. The patient has 6 weeks amenorrhea, a 3 cm left adnexal mass containing a gestational sac, and mild vaginal bleeding with abdominal pain, but no signs of rupture (hemodynamic stability, no acute peritonitis). According to Indian guidelines (FOGSI, ICOG) and Harrison, medical management with single-dose methotrexate is the first-line treatment for unruptured ectopic pregnancy when hCG <5000 mIU/mL, the patient is hemodynamically stable, and there is no evidence of rupture. The single-dose regimen (50 mg/m² IM) is preferred in India over multi-dose protocols because it has comparable efficacy, better compliance, and fewer side effects. The absence of fetal cardiac activity does not contraindicate methotrexate—in fact, it indicates the pregnancy is already failing, making medical management more likely to succeed. Methotrexate works by inhibiting dihydrofolate reductase, halting DNA synthesis in rapidly dividing trophoblastic cells, leading to resorption of the ectopic pregnancy. Success rates exceed 90% when hCG <5000 mIU/mL and the mass is <3.5 cm, both criteria met here. ## Why the other options are wrong **A. Salpingectomy** — Salpingectomy is surgical management reserved for ruptured ectopic pregnancy, recurrent ipsilateral ectopic pregnancy, or when medical management fails or is contraindicated. In an unruptured, hemodynamically stable patient with hCG <5000 mIU/mL, surgery is unnecessarily invasive and sacrifices future fertility. This option represents overtreatment and ignores the patient's infertility history—tube preservation is paramount. **B. Expectant management** — Expectant management (watchful waiting) is considered only in highly selected cases with hCG <1000 mIU/mL, no gestational sac, and reliable follow-up. This patient has hCG 2800 mIU/mL with a visible gestational sac—expectant management carries unacceptable risk of rupture and hemorrhage. The presence of a sac mandates active intervention, not observation. **C. Milking of the tube** — Milking (manual expression of products of conception) is an obsolete, non-evidence-based procedure with high failure rates and risk of rupture. It is not recommended by any modern guideline (FOGSI, ICOG, ACOG, RCOG). This option represents outdated practice and is a classic NBE trap for students who confuse it with legitimate conservative options. ## High-Yield Facts - **hCG <5000 mIU/mL** is the cutoff for medical management eligibility in unruptured ectopic pregnancy; this patient at 2800 mIU/mL qualifies. - **Single-dose methotrexate (50 mg/m² IM)** is the preferred Indian regimen for ectopic pregnancy—comparable efficacy to multi-dose, better compliance, fewer toxicities. - **Absence of fetal cardiac activity** does not contraindicate methotrexate; it indicates failing pregnancy and improves medical management success. - **Ectopic mass <3.5 cm** is a criterion for medical eligibility; this patient's 3 cm mass qualifies. - **Hemodynamic stability and no peritonitis** rule out rupture and permit conservative management; surgery is reserved for rupture or failed medical therapy. - **Tube preservation** is critical in infertile patients; medical management avoids salpingectomy and maintains future fertility potential. ## Mnemonics **METHO criteria for ectopic pregnancy** **M**ass <3.5 cm, **E**mbryo without cardiac activity (or no sac), **T**ube intact (unruptured), **H**CG <5000, **O**rgan function normal (renal, liver, blood counts). All present = methotrexate eligible. **hCG cutoffs in ectopic management** **<1000**: Expectant management possible. **1000–5000**: Medical (methotrexate). **>5000**: Surgery preferred. This patient at 2800 = methotrexate zone. ## NBE Trap NBE pairs "ectopic pregnancy" with "salpingectomy" to trap students who default to surgery without assessing hCG, mass size, and hemodynamic stability. The presence of a gestational sac (visible on ultrasound) is a red herring—it does not mandate surgery if medical criteria are met. Students must learn that medical management is *first-line* for unruptured ectopic, not a fallback. ## Clinical Pearl In Indian infertility clinics, methotrexate is the workhorse for ectopic pregnancy because it preserves the fallopian tube—critical for women undergoing ART or seeking natural conception. A single IM dose avoids repeated visits and lab monitoring burden common in multi-dose regimens, improving compliance in resource-limited settings. _Reference: DC Dutta's Textbook of Obstetrics Ch. 11 (Ectopic Pregnancy); FOGSI Guidelines on Management of Ectopic Pregnancy; Harrison Ch. 410_